Company news
MediWound Ltd. news in 2021
MediWound Ltd.'s news releases, calls and decks from 2021, newest first.
MediWound Announces Positive Initial Data from its U.S. Phase 2 Pharmacology Study of EscharEx Showing Effective and Rapid Debridement in Chronic and Hard to Heal Wounds
December 19, 2021
MediWound Completes Enrollment of its EscharEx U.S. Phase 2 Adaptive Design Study
December 5, 2021
MediWound Reports Third Quarter 2021 Financial Results
November 15, 2021
MediWound to Report Third Quarter 2021 Financial Results and Host a Conference Call and Webcast on November 16, 2021
November 3, 2021
MediWound Announces Peer-Reviewed Publication of EscharEx In-Vivo Head-to-Head Comparator Study in the Journal of Wound Care
October 3, 2021
MediWound Reports Second Quarter Financial Results
August 9, 2021
MediWound to Report Second Quarter 2021 Financial Results and Host a Conference Call and Webcast on August 10, 2021
August 1, 2021
MediWound Announces Positive Outcome of Interim Assessment for its EscharEx U.S. Phase 2 Adaptive Design Study
July 27, 2021
MediWound Announces Initiation of U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
July 25, 2021
MediWound Announces Positive Topline Results from Phase 3 Pediatric Study (CIDS) of NexoBrid for Eschar Removal of Severe Thermal Burns
July 19, 2021
MediWound Announces Peer-Reviewed Paper Detailing EscharEx Phase 2 Randomized Control Trial Results Published in the Online Wound Repair and Regeneration Journal
July 8, 2021
MediWound Receives Complete Response Letter from U.S. FDA for NexoBrid Biologics License Application
June 28, 2021
MediWound Completes Patient Enrollment for Interim Assessment of its U.S. EscharEx Phase 2 Adaptive Design Study
June 8, 2021
MediWound Reports First Quarter 2021 Financial Results
May 4, 2021
MediWound to Report First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 5, 2021
April 25, 2021
MediWound Enrolls First Patient in Phase 2 Pharmacology Study of EscharEx
April 21, 2021
MediWound Reports Fourth Quarter and Full-Year 2020 Financial Results
February 24, 2021
MediWound Launches Clinical Development Program for Treatment of Non-Melanoma Skin Cancer
February 21, 2021
MediWound Provides Progress Update on Its EscharEx Clinical Development Program
January 10, 2021